These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30144108)

  • 1. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis.
    Ciocan D; Voican CS; Wrzosek L; Hugot C; Rainteau D; Humbert L; Cassard AM; Perlemuter G
    Aliment Pharmacol Ther; 2018 Nov; 48(9):961-974. PubMed ID: 30144108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis.
    Ciocan D; Rebours V; Voican CS; Wrzosek L; Puchois V; Cassard AM; Perlemuter G
    Sci Rep; 2018 Mar; 8(1):4822. PubMed ID: 29555983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity.
    Smirnova E; Puri P; Muthiah MD; Daitya K; Brown R; Chalasani N; Liangpunsakul S; Shah VH; Gelow K; Siddiqui MS; Boyett S; Mirshahi F; Sikaroodi M; Gillevet P; Sanyal AJ
    Hepatology; 2020 Jul; 72(1):271-286. PubMed ID: 32056227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.
    Llopis M; Cassard AM; Wrzosek L; Boschat L; Bruneau A; Ferrere G; Puchois V; Martin JC; Lepage P; Le Roy T; Lefèvre L; Langelier B; Cailleux F; González-Castro AM; Rabot S; Gaudin F; Agostini H; Prévot S; Berrebi D; Ciocan D; Jousse C; Naveau S; Gérard P; Perlemuter G
    Gut; 2016 May; 65(5):830-9. PubMed ID: 26642859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis.
    Philips CA; Phadke N; Ganesan K; Ranade S; Augustine P
    Indian J Gastroenterol; 2018 May; 37(3):215-225. PubMed ID: 29931479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bile acids profiles are altered without change of the gut microbiota composition following a seven-day prednisolone therapy in severe alcoholic hepatitis.
    Esparteiro D; Fouquet G; Courtois A; Jedraszak G; Marticho L; Gourdel M; Billon-Crossouard S; Croyal M; Naassila M; Nguyen-Khac E; Marcq I
    Gut Microbes; 2024; 16(1):2382767. PubMed ID: 39078043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M; Wang AY; Bandsma R; Comelli EM; Arendt BM; Zhang L; Fung S; Fischer SE; McGilvray IG; Allard JP
    PLoS One; 2016; 11(5):e0151829. PubMed ID: 27203081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of bile acid profile by gut microbiota in chronic hepatitis B.
    Wang X; Chen L; Wang H; Cai W; Xie Q
    J Cell Mol Med; 2020 Feb; 24(4):2573-2581. PubMed ID: 31925905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease.
    Blake AB; Guard BC; Honneffer JB; Lidbury JA; Steiner JM; Suchodolski JS
    PLoS One; 2019; 14(10):e0224454. PubMed ID: 31671166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.
    Puri P; Liangpunsakul S; Christensen JE; Shah VH; Kamath PS; Gores GJ; Walker S; Comerford M; Katz B; Borst A; Yu Q; Kumar DP; Mirshahi F; Radaeva S; Chalasani NP; Crabb DW; Sanyal AJ;
    Hepatology; 2018 Apr; 67(4):1284-1302. PubMed ID: 29083504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
    Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
    Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
    Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis].
    Shalikiani NV; Bakulin IG; Dubinkina VB; Ishchenko DS; Alexeev DG; Tyakht AV; Pavlenko AV; Ilyina EN; Kostryukova ES; Taraskina AE; Skorodumova LO; Maev IV; Govorun VM
    Ter Arkh; 2015; 87(12):59-65. PubMed ID: 26978420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.